Gemcitabine is used for advanced and metastatic pancreatic cancers and is also indicated for the treatment of intermediate and advanced non-small cell lung cancers.
Gemcitabine mainly acts on the DNA synthesis phase, that is, the S phase, and under certain conditions, it can prevent the progression of the G1 phase to the S phase. Gemcitabine has the characteristics of broad anticancer spectrum, unique mechanism of action, low toxicity, no cross-resistance to other chemotherapy drugs, and no superposition of toxic reactions.
|Apperance||White crystalline powder||Complies|
|Residue on ignition||≤0.2%||0.03%|
|Related substances||Impurity A≤0.1%|
|Loss on drying||≤5.0%||0.1%|
|Appearance:||White crystalline powder|
|Package details:||100g,1kg/foil bag;25kg/drum|
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!